Launch of Venus Nova
Venus Concept announced the 510 clearance for Venus Nova, the first product from their new focused R&D strategy. Venus Nova is designed to redefine noninvasive treatments and is expected to contribute to the company's long-term growth.
Improved Balance Sheet
The company made significant progress in improving its balance sheet by converting $11.5 million in debt to equity and raising $3.9 million in gross proceeds through equity capital market transactions.
Growth in Energy-Based Devices
Sales of energy-based devices increased 2% year over year, indicating stabilization in this segment despite challenging market conditions.